SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-005071
Filing Date
2019-03-18
Accepted
2019-03-18 07:30:15
Documents
4
Period of Report
2019-03-15
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 66135
2 EXHIBIT 3.1 ex3_1.htm EX-3.1 10795
3 EXHIBIT 3.2 ex3_2.htm EX-3.2 11185
4 EXHIBIT 99.1 ex99_1.htm EX-99.1 13896
  Complete submission text file 0001140361-19-005071.txt   103505
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 19686811
SIC: 2834 Pharmaceutical Preparations